Induction Chemotherapy (Record no. 28983)

MARC details
000 -LEADER
fixed length control field 02577nam a22002897a 4500
001 - CONTROL NUMBER
control field 20241001090036.0
003 - CONTROL NUMBER IDENTIFIER
control field 20241001090036.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241001091034.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241001b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-319-28771-3
International Standard Book Number 978-3-319-28773-7
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994 15
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Karl Reinhard Aigner
245 ## - TITLE STATEMENT
Title Induction Chemotherapy
Remainder of title Systemic and Locoregional
250 ## - EDITION STATEMENT
Edition statement Second Edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Burghausen Germany |
Name of publisher, distributor, etc. Springer-Verlag Berlin Heidelberg |
Date of publication, distribution, etc. 2016
300 ## - PHYSICAL DESCRIPTION
Extent 501 Pages
Extent Includes References
490 ## - SERIES STATEMENT
Series statement DOI 10.1007/978-3-319-28773-7
520 ## - SUMMARY, ETC.
Summary, etc. This book presents the full range of management techniques and practices used in induction chemotherapy – both systemic and locoregional - by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of integrated treatment schedules. All those responsible for treating patients with locally advanced cancers may find new, interesting aspects of locoregional cancer management and will find this book to be an invaluable source of up-to-date information.<br/><br/>Throughout the world, induction chemotherapy is being used as part of an integrated plan of management for locally advanced, solid tumors, while systemic chemotherapy is most commonly used to shrink primarily non-operable tumors. In cases of poorly or nonresponsive tumors, attempts have been made to administer chemotherapeutics via the arterial route in order to achieve higher localized drug exposure and response rates. Such therapies are being practiced worldwide in independent, remote departments in universities, teaching hospitals and clinical schools. Frequently, however, these teams remain relatively unaware of the work being done in other institutions, which may slow further progress
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Family medicine, Interventional radiology, Medical / Allied Health Services / Imaging Technologies, Medical / Clinical Medicine, Medical / Family & General Practice, Medical / Oncology / General, Medical / Practice Management & Reimbursement, Medical / Radiology, Radiotherapy & Nuclear Medicine, Medical / Surgery / General, Oncology, Surgery, Medical / Chemotherapy, Chemotherapy, General practice (Medicine), Medicine.
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Frederick O. Stephens
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="DOI 10.1007/978-3-319-28773-7">DOI 10.1007/978-3-319-28773-7</a>
Link text DOI 10.1007/978-3-319-28773-7
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 10/01/2024   20241001090036.0 10/01/2024 10/01/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024